249 related articles for article (PubMed ID: 36683389)
1. Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.
Biscarini F; Masetti G; Muller I; Verhasselt HL; Covelli D; Colucci G; Zhang L; Draman MS; Okosieme O; Taylor P; Daumerie C; Burlacu MC; Marinò M; Ezra DG; Perros P; Plummer S; Eckstein A; Salvi M; Marchesi JR; Ludgate M
J Clin Endocrinol Metab; 2023 Jul; 108(8):2065-2077. PubMed ID: 36683389
[TBL] [Abstract][Full Text] [Related]
2. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
[TBL] [Abstract][Full Text] [Related]
4. The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
Li Y; Luo B; Tong B; Xie Z; Cao J; Bai X; Peng Y; Wu Y; Wang W; Qi X
J Endocrinol Invest; 2023 Feb; 46(2):305-317. PubMed ID: 35986869
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.
Hou J; Tang Y; Chen Y; Chen D
Front Cell Infect Microbiol; 2021; 11():739707. PubMed ID: 35004341
[TBL] [Abstract][Full Text] [Related]
6. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
7. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy.
Shi TT; Xin Z; Hua L; Wang H; Zhao RX; Yang YL; Xie RR; Liu HY; Yang JK
J Endocrinol Invest; 2021 Feb; 44(2):297-310. PubMed ID: 32449092
[TBL] [Abstract][Full Text] [Related]
9. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
10. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy.
Khamisi S; Lundqvist M; Engström BE; Larsson A; Karlsson FA; Ljunggren Ö
Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):236-241. PubMed ID: 36706788
[TBL] [Abstract][Full Text] [Related]
11. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Relapse of Hyperthyroidism in Treated Graves' Disease with Orbitopathy by Serial Measurements of TSH-Receptor Autoantibodies.
Stöhr M; Oeverhaus M; Lytton SD; Horstmann M; Zwanziger D; Möller L; Stark A; Führer-Sakel D; Bechrakis N; Berchner-Pfannschmidt U; Banga JP; Philipp S; Eckstein A
Horm Metab Res; 2021 Apr; 53(4):235-244. PubMed ID: 33618407
[TBL] [Abstract][Full Text] [Related]
13. High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease.
Kahaly GJ; Wüster C; Olivo PD; Diana T
J Clin Endocrinol Metab; 2019 Jul; 104(7):2561-2568. PubMed ID: 30753531
[TBL] [Abstract][Full Text] [Related]
14. Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.
De Bellis A; Conzo G; Cennamo G; Pane E; Bellastella G; Colella C; Iacovo AD; Paglionico VA; Sinisi AA; Wall JR; Bizzarro A; Bellastella A
Endocrine; 2012 Apr; 41(2):320-6. PubMed ID: 22169963
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for Graves' Orbitopathy in surgical patients-Results of a 10-year retrospective study with review of the literature.
Tabriz N; Gruben A; Uslar V; Weyhe D
Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00210. PubMed ID: 33532627
[TBL] [Abstract][Full Text] [Related]
16. Clinical review: Clinical utility of TSH receptor antibodies.
Barbesino G; Tomer Y
J Clin Endocrinol Metab; 2013 Jun; 98(6):2247-55. PubMed ID: 23539719
[TBL] [Abstract][Full Text] [Related]
17. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
[TBL] [Abstract][Full Text] [Related]
19. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
Kahaly GJ
J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
[TBL] [Abstract][Full Text] [Related]
20. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
